New drug sales help boost Novartis Q1 profit (Update)
Strong new drug sales and higher operating income helped Swiss pharmaceutical firm Novartis AG report a 24 percent rise in first-quarter profit.
Apr 24, 2014
0
0
Strong new drug sales and higher operating income helped Swiss pharmaceutical firm Novartis AG report a 24 percent rise in first-quarter profit.
Apr 24, 2014
0
0
(HealthDay)—Physicians can reap significant financial benefits by extending their office hours to include non-traditional hours, according to an article published Jan. 8 in Medical Economics.
Feb 17, 2014
0
0
Swiss pharmaceuticals giant Roche on Thursday posted an 18-percent hike in net profit for 2013, driven particularly by rising sales of its cancer-fighting drugs.
Jan 30, 2014
0
0
Swiss drug maker Novartis AG reported a 2 percent rise in fourth-quarter net profit Wednesday, helped by delays in generic competition to its blockbuster drugs.
Jan 29, 2014
0
0
German chemicals and pharmaceuticals giant Merck KGaA said Thursday it is raising its full-year operating profit forecast thanks to improving sales and positive cost-cutting effects.
Nov 14, 2013
0
0
India's second-largest drugmaker Dr Reddy's Laboratories on Tuesday reported a 69.4 percent jump in quarterly net profit, as profit margins rose helped by improved sales.
Oct 31, 2013
0
0
German chemicals and pharmaceuticals group Bayer, maker of Aspirin, said on Thursday that new pharmaceutical products and favourable agrochemical prices gave profits a fillip in the third quarter.
Oct 31, 2013
0
0
French pharmaceutical group Sanofi reported a slump in profits for the third quarter of the year on Wednesday owing to the lagging effects of the ending of exclusive patent rights.
Oct 30, 2013
0
0
Biotech drugmaker Amgen Inc. said Tuesday that its third-quarter profit jumped 24 percent, trouncing analysts' expectations, as sales of more than a half-dozen of its drugs increased by double digits.
Oct 22, 2013
0
0
Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends contributed to ...
Oct 22, 2013
0
0